跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ARIXTRA fondaparinux sodium 5.0mg/0.4mL solution for injection syringe
Approved
STANDARD
ARIXTRA fondaparinux sodium 5.0mg/0.4mL solution for injection syringe
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
f772afbc5c621b53
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f772afbc5c621b53
Product Name
ARIXTRA fondaparinux sodium 5.0mg/0.4mL solution for injection syringe
Artg Id
97798
Artg Name
ARIXTRA fondaparinux sodium 5.0mg/0.4mL solution for injection syringe
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2004-11-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/589cf79ce8bec2912bba3e0e565ba15c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
f772afbc5c621b53
Type
Standard
Back to TGA Approvals
ARIXTRA fondaparinux sodium 5.0mg/0.4mL solution for injection syringe - TGA Drug Approval Details
